Pricing
Navire Pharma
Contact
No bio yet
Eli Wallace
Chief Scientific Officer, Residence for Oncology
6 people, 0 jobs
This person is not in any offices
Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat cancers.
Industries
Headquarters
Employees
Links
EngineRoom
Unison Globus
New York Stem Cell Foundation
Resilinc
Puma Energy
View more